Lipidil Supra, promising preventive effects for coronary heart disease

Green Cross said that a new anti-cholesterol drug, Lipidil Supra (fenofibrate) showed a promising effect for the diabetic patients to prevent coronary heart diseases and to reduce significantly a risk of non-fatal myocardiac infarction.

Prof. Anthony Kitty of the University of Sydney in Australia found the above effect on his study for 9,795 of the type 2 diabetic patients who were partici...